Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Letter to the Editor

Reply to ‘Apropos “Evaluation of Serological Diagnostic Tests for Typhoid Fever in Papua New Guinea Using a Composite Reference Standard”’

Andrew Greenhill, Valentine Siba, Paul Horwood
Andrew Greenhill
aPapua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
bMonash University, Gippsland Campus, Churchill, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentine Siba
aPapua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Horwood
aPapua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.00724-12
  • Article
  • Info & Metrics
  • PDF
Loading

REPLY

We acknowledge the importance of quality control in the delivery of diagnostic services and in medical research. The Papua New Guinea Institute of Medical Research (PNGIMR) conducts research in accordance with international standards where applicable (e.g., good clinical practice guideline compliance for intervention studies, World Health Organization National Influenza Centre, etc). In our typhoid diagnostics study (1), we planned and conducted the study in accordance with Standards for Reporting of Diagnostic Accuracy (STARD) guidelines (2).

While the PNGIMR has the capacity to conduct research meeting international standards, the delivery of health care and diagnostic services in Papua New Guinea (PNG) is poor by international standards. A recent survey found that only 15% of health care facilities had the capacity to diagnose malaria by either microscopy or rapid diagnostic tests (RDTs) (3). Conducting baseline surveys for Widal antibodies requires a level of laboratory capacity comparable to that needed for conducting malaria microscopy. We agree with the authors of the foregoing letter that the Widal test requires collection of baseline data to enable a clinically relevant cutoff titer to be determined (4). In PNG, such surveillance would need to be conducted throughout the country on account of the differing levels of endemicity of typhoid fever and also at regular intervals (or ongoing) due to the temporal changes in endemicity (1, 5). However, in PNG, ongoing surveillance for quality control (QC) and local mean antibody titer is beyond the means of the already overburdened health care services.

Due to the requirement for locally relevant baseline data, along with numerous other shortcomings (the reagents require cold-chain delivery and storage, conducting the test requires more laboratory expertise than a rapid test, and interpretation of the test result is subjective), we believe further efforts should be invested in the development and evaluation of typhoid fever RDTs. The rollout of a typhoid RDT would need careful management and should include laboratory training and national uniformity of the RDT used.

The global burden of typhoid fever is high, and it remains one of the most important causes of febrile illness globally on account of the severity of illness and the poor outcomes if untreated. Following the success of improved prevention, diagnosis, and treatment of malaria, the next step is to better diagnose and treat the other causes of fever. In countries such as PNG, QC should not be overlooked but should not burden health care services. RDTs typically have some QC mechanisms incorporated, target antibodies specific to the pathogen causing the disease, and reduce (though do not necessarily alleviate) the need for mean antibody titer data. Such tests are becoming competitively priced relative to Widal reagents and will be central to improved diagnosis of febrile illnesses such as typhoid fever.

FOOTNOTES

  • This is a response to a letter by Arya and Agarwal (doi:10.1128/CVI.00635-12).

  • Copyright © 2013, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Siba V,
    2. Horwood PF,
    3. Vanuga K,
    4. Wapling J,
    5. Sehuko R,
    6. Siba PM,
    7. Greenhill AR
    . 2012. Evaluation of serological diagnostic tests for typhoid fever in Papua New Guinea using a composite reference standard. Clin.Vaccine Immunol. 19:1833–1837.
    OpenUrl
  2. 2.↵
    1. Banoo S,
    2. Bell D,
    3. Bossuyt P,
    4. Herring A,
    5. Mabey D,
    6. Poole F,
    7. Smith PG,
    8. Sriram N,
    9. Wongsrichanalai C,
    10. Linke R,
    11. O'Brien R,
    12. Perkins M,
    13. Cunningham J,
    14. Matsoso P,
    15. Nathanson CM,
    16. Olliaro P,
    17. Peeling RW,
    18. Ramsay A
    . 2006. Evaluation of diagnostic tests for infectious diseases: general principles. Nat. Rev. Microbiol. 4(Suppl):S21–S31.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Kurumop SF,
    2. Pulford J,
    3. Mueller I,
    4. Siba PM,
    5. Hetzel MW
    . Diagnostic capacity and anti-malarial availability in Papua New Guinea prior to the introduction of a revised national malaria treatment protocol. P. N. G. Med. J., in press.
  4. 4.↵
    1. Arya SC,
    2. Agarwal N
    . 2013. Apropos “Evaluation of serological diagnostic tests for typhoid fever in Papua New Guinea using a composite reference standard”. Clin. Vaccine Immunol. 20:317.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Passey M
    . 1995. The new problem of typhoid fever in Papua New Guinea: how do we deal with it? P. N. G. Med. J. 38:300–304.
    OpenUrlPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Reply to ‘Apropos “Evaluation of Serological Diagnostic Tests for Typhoid Fever in Papua New Guinea Using a Composite Reference Standard”’
Andrew Greenhill, Valentine Siba, Paul Horwood
Clinical and Vaccine Immunology Jan 2013, 20 (2) 318; DOI: 10.1128/CVI.00724-12

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reply to ‘Apropos “Evaluation of Serological Diagnostic Tests for Typhoid Fever in Papua New Guinea Using a Composite Reference Standard”’
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reply to ‘Apropos “Evaluation of Serological Diagnostic Tests for Typhoid Fever in Papua New Guinea Using a Composite Reference Standard”’
Andrew Greenhill, Valentine Siba, Paul Horwood
Clinical and Vaccine Immunology Jan 2013, 20 (2) 318; DOI: 10.1128/CVI.00724-12
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • REPLY
    • FOOTNOTES
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X